Journal article
Authors list: Neumann, Elena; Khawaja, Kiran; Mueller-Ladner, Ulf
Publication year: 2014
Pages: 429-436
Journal: Nature Reviews Rheumatology
Volume number: 10
Issue number: 7
ISSN: 1759-4790
eISSN: 1759-4804
DOI Link: https://doi.org/10.1038/nrrheum.2014.62
Publisher: Nature Research
Abstract:
G protein-coupled receptors (GPCRs) are transmembrane receptor proteins that allow the transfer of signals across the cell membrane. In addition to their physiological role, GPCRs are involved in many pathophysiological processes including pathways relevant in rheumatoid arthritis (RA), osteoarthritis (OA) and psoriatic arthritis. Two-thirds of all currently available drugs target GPCRs directly or indirectly. However, the detailed mechanism of GPCR signalling is still unclear. Selective modification of GPCR-dependent signalling cascades to inhibit disease progression in rheumatic diseases is now being investigated. One approach is to use antibodies against ligands activating GPCRs. However, several GPCRs are known to be activated by only one ligand. In this case, targeting the receptor itself is a promising approach. So far, more information is available on GPCR action in RA as compared with OA, and even less information is available for other rheumatic diseases. Additional research on the role of GPCRs involved in the pathophysiology of rheumatic diseases is required to develop specific therapeutic approaches.
Citation Styles
Harvard Citation style: Neumann, E., Khawaja, K. and Mueller-Ladner, U. (2014) G protein-coupled receptors in rheumatology, Nature Reviews Rheumatology, 10(7), pp. 429-436. https://doi.org/10.1038/nrrheum.2014.62
APA Citation style: Neumann, E., Khawaja, K., & Mueller-Ladner, U. (2014). G protein-coupled receptors in rheumatology. Nature Reviews Rheumatology. 10(7), 429-436. https://doi.org/10.1038/nrrheum.2014.62
Keywords
ANTAGONIST; DOUBLE-BLIND; INTERNATIONAL UNION; METHOTREXATE